Search

everythinglearnresearchcommunity

for

Search:↓

New gene mutations linked to skin conditions were found, bacteria and chemicals may worsen acne, a dog mutation could exist in humans, virus-like elements might be involved in psoriasis, and a vitamin D3 treatment doesn't prevent chemotherapy-related hair loss.

The document concludes that understanding the genes and pathways involved in hair growth is crucial for developing treatments for hair diseases.

Curly hair is influenced by specific genetic variations.

The document concludes that adenosine receptor agonists have potential for treating various conditions, but only a few are approved due to challenges like side effects and the need for selective activation.

Antiandrogens have important biological effects, but more research is needed to understand them fully and compare their effectiveness and side effects to other treatments.

MR antagonists may improve skin health and wound healing, especially in aging.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

14,15-EET may help reduce poststroke pain by affecting certain brain proteins.

Beta-blockers and anti-anginal medications have various side effects and interactions that require careful monitoring and individualized treatment.

Adiantum capillus extract reduces pain and swelling in animals.

Nitrendipine and nifedipine effectively block muscle contractions, while papaverine relaxes them and minoxidil needs high amounts to work.

Direct vasodilators and sympatholytic agents are still useful for certain conditions despite being less common due to side effects and newer drugs.

New steroids were effective in blocking male hormone receptors in hamster prostates.

Blocking GABA(A) receptors increases neuron sensitivity, showing GABA and glycine have different roles in pain.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

Using existing drugs for new purposes could be a cost-effective way to treat chest pain and non-clogged heart arteries, with some drugs for lung blood pressure showing promise but needing more testing.

Certain drugs can reduce bladder muscle contractions, potentially helping treat bladder diseases.

New compounds were made that are promising for prostate cancer therapy.

New oral anticoagulants are safer and easier to use with new reversal agents for bleeding emergencies.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Therapies targeting the androgen receptor are being developed to treat prostate cancer and improve bone and muscle health.

New progesterone-based compounds can block male hormones.

New compounds may help treat heart disease by activating specific potassium channels.

AH-001 could be a safer and more effective treatment for hair loss.

Arteannuin might work against cancer and Alzheimer's by targeting neprilysin.

Potassium channel openers could help treat cardiovascular diseases and asthma but require better targeting to specific tissues for effective use.

Pfizer found that pantolactam-based compounds can reduce sebum (skin oil) production when applied topically.